Objectives: Legislation and health policy enabling nurses and pharmacists to prescribe a comprehensive range of medicines has been in place in the UK since 2006. Our objective was to evaluate the clinical appropriateness of prescribing by these professionals.
Introduction
As part of the modernization of the National Health Service (NHS) in the UK, over the past decade the Government has introduced a series of legislative and health policy changes aimed at increasing the scope and scale of prescribing of medicines by non-medical professionals to increase patient access and choice, make best use of health professionals' skills, whilst ensuring patient safety. 1 This began with the introduction of nurses prescribing from a limited formulary and incremental expansion of prescribing responsibilities continued until the most recent policy development in 2006, enabling suitably qualified nurses and pharmacists to prescribe any medicine for any medical condition within their competence, including for nurses, some controlled drugs. Independent prescribing is defined as "prescribing by a practitioner responsible and accountable for the assessment of patients with undiagnosed or diagnosed conditions and for decisions about the clinical management required, including prescribing". Supplementary prescribing, where prescriptive authority is delegated to a nurse or pharmacist under specific conditions included in a patient's individualized clinical management plan, was introduced in 2003. Suitably qualified nurses and pharmacists undertake a 26 day training programme. Currently, there are 19,000 nurse independent prescribers (NIPs) and 1,500 pharmacist independent prescribers (PIPs) in the UK in primary care, hospitals, community clinics, urgent care services and patients' homes.
Patients are generally satisfied with their experiences of nurse and pharmacist prescribing, as regards increased access and the information provided. 2, 3 Prescribers have reported a range of positive consequences including nurses' ability to independently deliver a complete episode of care and better use of skills 4 as well as improved relationships with other health care professionals. 3 However, studies have also highlighted issues concerning nurses' knowledge and skills for a prescribing role, including pharmacological knowledge. 5, 6 Other studies report doctors' concerns about pharmacist independent prescribing 7 including their limited skills in history-taking. 8 Critics 9 have called for nurse prescribing to be restricted to advanced nursing practice with complementary advanced training in skills such as assessment, diagnosis and clinical decision-making. 10 Most research into nurse prescribing is restricted to descriptive, self-reports of nurses prescribing from a limited formulary 2 with little evidence of the quality and safety of prescribing. A national evaluation of nurse and pharmacist independent prescribing in England, 11 was undertaken to investigate the quality, safety, and clinical appropriateness of independent prescribing by nurses and pharmacists. This paper reports on the last aspect.
Methods
The method was piloted by one of the authors (SL), which demonstrated feasibility and validity in assessing the clinical appropriateness of nurses' prescribing decisions. 12 
Sample of consultations
Examples of nurse and pharmacist prescribing consultations were collected from the nine case study sites taking part in the main study. The sites were selected purposively from 389 (43.6%)) of 840 NIP respondents and 75 (52.8%) of 143 PIP respondents who expressed an interest when they participated in a national survey in the first phase of the study. The aim of purposive sampling was to produce representativeness and diversity 13 of sites. Inclusion criteria were: NIP or PIP prescribing frequently for one of four specified conditions; prescribing at least 10 items each week. Eligible sites were stratified according to profession of prescriber and type of setting (e.g. general practice, Walk-in Centre, hospital) and were consecutively sampled and approached to participate. For some types of site, several declined participation before enough were identified.
We aimed to collect 10 consultations from each site in which a prescription was issued by a nurse or pharmacist. Consultations with patients under the age of 16 were excluded. Likely clinics (e.g. NIP-or PIP-led) were purposively sampled and consultations were audio-recorded. The time taken to collect 10 consultations varied from one to four NMP clinics, within a two week period. For each consultation details of the patient (age, sex, presenting condition and diagnosis), their clinical history (other conditions, medications taken) and the prescribed medicine, dose and directions, were extracted from patient records. All recordings were transcribed verbatim. For consultations in which more than one medicine was prescribed, the medicine relating to the patient's presenting condition was selected as the focus for the analysis.
Medication Appropriateness Index
The study focused on the clinical appropriateness of prescribing, using the Medication Appropriateness Index (MAI). 14 This has demonstrated reliability and validity in studies of medical prescribing when applied to patient records in a variety of settings. 12,14 -17 A modified version of the MAI applied to transcripts of prescribing consultations has been shown to be a feasible and valid method of evaluating prescribing by nurses in an earlier study. 12 The MAI consists of ten criteria (indication, effectiveness, dosage, directions, practicality, drug-drug interaction, drug-disease interaction, duplication, duration, cost) to quantify medication appropriateness. In the modified version each prescribed medication is rated as 'appropriate' or 'inappropriate' on each of these criteria. A summated score, based on weighted indicators, is also calculable. The modified tool is also designed to allow overall qualitative comments on the safety and effectiveness of each prescribing episode.
Sample of raters
We used health care professionals with recognized experience in prescribing to rate the nurses' and pharmacists' prescribing decisions. Inclusion criteria for rater selection were: established prescribing expertise; current prescriber; and prescribing experience across a range of clinical conditions. A mix of medical, pharmacist and nursing professionals was sought. Raters were identified by recommendation of the study's Advisory Group, as well as through research team members' national networks of prescribers. The raters comprised 10 medical prescribers, seven pharmacists and three nurse prescribers.
To assess inter-rater reliability four independent assessments were made of each consultation. The sample size of 100 consultations each assessed by four raters ensured acceptable precision in calculating measures of reliability. 18 This required each of the 20 raters to assess 20 consultations. Transcripts were randomly allocated to raters, ensuring that each transcript was sent to four different raters.
Data analysis
A weighted total score was calculated, using weights applied to each indicator as validated and used in previous research; 15, 16 3 for indication and effectiveness; 2 for dosage, directions, drug-drug interaction and drug-disease interaction; 1 for practical directions, duplication, duration and cost. Data were analysed using STATA software to produce descriptive statistics. Inter-rater reliability was assessed using percent positive agreement and percent negative agreement for each MAI indicator. As in previous studies 15, 19, 20 using multiple raters, agreement was defined as two or more raters giving the same rating. The intraclass correlation coefficient for assessments of total scores was assessed using analysis of variance. Brief qualitative comments on the overall prescribing episode received from raters in response to open items were extracted and pasted onto a spreadsheet. A simple thematic analysis was applied to identify key themes. 21 Themes were then quantified, as a means of validating impressions gained. 22 
Results

Medicines prescribed
Details of the medicines that were prescribed and rated by site are shown in the Appendix (http:// jhsrp.rsmjournals.com/lookup/suppl/doi:10.1258/jhsrp. 2012.011090/-/DC1). The majority of medicines prescribed by PIPs were long-term regimes, such as those for lipid management and hypertension. Medicines prescribed by NIPs were more mixed: NIPs at the Walk-in-Centre and Out-of-Hours sites were prescribing for acute conditions such as infections while those in general practices prescribed for both acute and long term conditions. Over half (25) of the medicines in the PIP sample were for cardiovascular conditions, and over half (27) in the NIP sample were for infections. Of the 100 consultations, 39% were follow up consultations where an initial diagnosis and/or medicine had previously been prescribed by this or another prescriber for the presenting condition. Of these, 34% were PIP consultations (70.8% of all PIP consultations), and 5% were with NIPs. Table 1 shows overall ratings of NIPs' and PIPs' consultations combined. Ratings of 'Not Known' ranged between 3% and 7% for eight of the 10 indicators. Higher numbers of 'Not Known' ratings were given for MAI indicators on duration of therapy and whether the drug prescribed was the least expensive alternative. Details on duration of therapy were not requested in the additional patient details, and the prescriber may have relied on the written prescription as a means of conveying duration of therapy to the patient or, for follow up consultations, the period to next review may have been self-evident to prescriber and patient and therefore not discussed. The higher number of 'Don't knows' for drugs' comparative cost may have reflected raters' lack of knowledge on this issue. Table 2 shows results of the ten MAI indicators applied to all consultations by prescriber profession. Tables 1 and  2 show that overall, raters judged NIPs and PIPs to be making clinically appropriate prescribing decisions across the range of MAI indicators. Table 2 highlights that, for all 100 consultations, eight out of 10 questions received mean appropriate ratings over 90%. For the indicators on correct directions and the cost of the drug prescribed, slightly lower rates were given.
Clinical appropriateness of prescribing
From a potential range of 0-18, with low scores indicating highest level of appropriateness, the overall mean weighted score across all consultations was 1.003 (SD 1.854) with a median of zero, and range 0-11. Twenty-eight percent of medicines prescribed had no inappropriate ratings, and 60% had no inappropriate ratings from three of four raters.
Inter-rater reliability
Our initial analysis of the data found high levels of positive agreement between raters. Of 4000 ratings, 3381 (84.5%) were positive. Excluding ratings recorded as 'Not Known', 'Not Applicable' or missing data this increases to 93.7%. Overall, Table 3 shows a relatively high level of 4 way agreement for five of the 10 indicators: 82% (unnecessary duplication), 76% (medicine interactions), 74% (effective), 69% (indicated), and 62% ( practical directions). Moderate levels of 4 way agreement were achieved for four indicators: 58% (dosage correct), 58% (medicine-condition interactions), 54% (duration acceptable), and 51% (directions correct). The lowest level of 4 way agreement was for comparative drug cost (39%). Only 228 (5.7%) of the assessments were rated inappropriate. Among these there were only two assessments with 4 way inappropriate agreement, 11 with 3 way agreement and 26 with two way agreement. Comparative drug cost was the primary source.
In the context of high levels of positive agreement and low levels of negative agreement the Kappa test statistic does not perform well. 23 Our remaining analysis therefore relies on separate measures of positive and negative agreement. We define 2 way or greater agreement as an overall approval rating. 16, 19, 20 Results for positive agreement indicate very good levels of agreement on appropriate scores overall, with values from 0.96 (comparative cost) to 0.99 (indicated, effective, medicine interactions, medicine-condition interactions, unnecessary duplication). Of the overall small proportion of inappropriate ratings, negative agreement values were .0.5 for three of the MAI indicators (dosage correct, directions correct, comparative cost). The remaining values were low or zero, reflecting the view reported elsewhere in the literature 16, 20, 24 that agreement on appropriateness is generally easier to achieve than consensus on inappropriate prescribing. The intraclass correlation No statistically significant differences (P , 0.05) were found between ratings for nurse and pharmacist prescribers' consultations on any of the MAI indicators. † For each MAI question applied to each consultation, the number of appropriate assessments given by the 4 raters were counted, giving a number in the range 0-4, or 0-3 or less if there are exclusions. (NApps). The number of inappropriate assessments were also counted (again producing a number in the range 0 -4, or less if there were exclusions). (NNApps). The mean appropriateness rating for each consultation is calculated as Napps/(Napps þ NNapps). The mean inappropriateness rating for each consultation is calculated as NNapps/(Napps þ NNapps) This reduces the set of 4 separate assessments of appropriateness/inappropriateness down to a single assessment -mean appropriateness/ inappropriateness. (Examples: Appropriateness: a consultation with 4 appropriate ratings would score 1.0 (100%). A consultation with 3 out of 4 would score 0.7 (75%). A consultation with 2 out of 3 and one missing would score 0.667(66%). An overall mean of appropriateness and inappropriateness for each MAI question was then calculated. coefficient for the weighted total scores was 0.289 (0.188-0.401). However, as the vast majority of ratings were positive, the lack of variation in scoring undermines this estimate. 25 We therefore re-coded weighted total scores, with scores grouped into those where the total weighted score was 0 and those where there was a score of 1-3 (at least one score of 3 or multiple other 1 and/or 2 disapprovals). For weighted total scores of 0, positive agreement based on 4 way approval was 0.42, for 3 way approval 0.79 and for 2 way approval was 0.95. For scores of 1-3, negative agreement based on 4 way agreement was 0.07, 3 way agreement 0.27 and 2 way agreement 0.54.
Raters' views of the safety and effectiveness of prescribing
Fourteen themes were identified from the 272 comments made. The themes identified, together with exemplar quotes, are shown in Table 4 . Some themes related to specific MAI items, such as dose or duration of drug prescribed, and provided amplification of a rater allocating an inappropriate rating. However, the most prevalent comments related to two themes: positive comments on the overall prescribing episode (88); and negative comments on history-taking, assessment, and diagnostic skills (52).
Positive comments on the prescribing episode
Many comments underscored the appropriateness of the prescribing episode. Views expressed included brief evaluation on the overall nature of the consultation, such as: "safe and effective start to treating a complex case" (Rater 6), and "not an easy patient with multiple problems. Appeared to do well!" (Rater 1). Raters also included more detailed comments on particular aspects of the prescribing episode or highlighted specific features of the prescriber's skills. For example, in relation to feedback and information-giving or in the assessment within the consultation: "A good encounter. The praise forgiving up smoking is particularly good. Also full explanations were given." (Rater 8)
"Very thorough evaluation. Checked with orthopaedics re: risk of joint infection and also undertaken to check need for tetanus immunization." (Rater 13)
History-taking, assessment, and diagnosis skills
Raters often judged that there was room for improvement in skills of either history-taking and assessment or diagnosis. In over 25% of consultation ratings, some comments were made. A number concerned queries about the appropriateness of prescribers' antibiotic prescribing:
"Trimethoprim not first line in pregnancy -and pregnancy was not ruled out with a test." (Rater 9)
"History-taking too brief. Penicillin V is indicated for tonsillitis but only if that's what the patient wants after discussion of natural history of the condition and risks/benefits of antibiotics. In this case, there was no discussion." (Rater 14) Other comments in this theme focused on the prescriber's potential inadequacies in history-taking, through failing to enquire about full details considered relevant to the medicine prescribed or the presenting patient: A minority of raters' comments focused on the accuracy of the diagnosis made by the prescriber, suggesting this was also an area that could have been improved:
"As this patient takes pentasa (a 5-ASA), ideally a full blood count should be done, to check for blood dyscrasia as a cause of recurrent throat infection." (Rater 1)
The assessments of prescribers' history-taking, assessment and diagnostic skills under this theme should be viewed in light of the fact that most ratings on the MAI indicator 'medicine indicated' were judged appropriate. Nevertheless, it highlights an issue that needs further consideration in terms of its implications for education and CPD of NIPs and PIPs.
Discussion
Clinical appropriateness of nurses' and pharmacists' prescribing decisions
Overall nurse and pharmacist prescribers were making clinically appropriate prescribing decisions. Previous research using the MAI to evaluate prescribing by nurses using only a limited formulary of drugs report similar results. 12, 26 There are no comparable data available for pharmacist prescribers as this is the first study to evaluate pharmacists using the MAI. Low levels of prescribing inappropriateness have been reported for pharmacist supplementary prescribing. 3 Any comparison of the study results with research into doctors' prescribing decisions should be made with caution due to lack of directly comparable studies. Studies of prescribing by doctors using the original MAI have, for example, utilised patient records, rated multiple medicines per patient and thus a larger number of prescribing decisions than in this study, involved only one or two raters, have not allowed for 'don't know' responses and have been conducted in settings (in-patients, out-patients, care homes) other than the predominantly primary care settings in this study. Additionally, those studies did not include raters' comments. However, most studies of medical prescribing 19,20,27 -29 report a range of inappropriate prescribing decisions for most indicators, which are broadly comparable with the results reported here. For example, baseline data from records of doctors' prescribing of 798 medicines reported 29.2% inappropriate decisions for correct directions and for 17.4% the dosage was incorrect. 30 Clinical appropriateness of professionals' prescribing decisions may also be indirectly compared using the mean MAI weighted score. In this study, the overall mean weighted score was 1.003 and results therefore suggest that the clinical significance of any inappropriate prescribing decisions by nurses and pharmacists was low. Other studies of prescribing by doctors have also generally reported low weighted scores, ranging from 2.2 27 2.4 19 to 3.79 31 and 4.52. 15 Generally, nurses and pharmacists tend to prescribe within specific clinical specialities. For example, nurses are frequently clinical nurse specialists in diabetes or respiratory conditions and many pharmacists have focused their prescribing role on cardio-vascular conditions, such as hypertension and coronary heart disease prevention. 11 Most doctors prescribe across a wider range of conditions and prescribe a far higher volume of medicines than nurses or pharmacists. 3 Nevertheless, NIPs and PIPs are making an increasing contribution to prescribing in the UK. Our data indicate that in England a nurse is prescribing in 1 in 3 general practices and a pharmacist is prescribing in 2% of general practices. 11 As measured by the clinical appropriateness of medicines they currently prescribe, our findings suggest that the nurses and pharmacists in this study were providing a prescribing service for patients that is comparable in quality and safety to prescribing by doctors.
Areas for quality improvement
The issue that attracted the most inappropriate ratings was that of the cost of the drug prescribed. Studies of doctors' prescribing have also recorded highest inappropriate ratings for cost. 19, 27 It has been suggested that drug costs may be less important to doctors than other clinical decisions when prescribing. Results of decisions about medicines' costs reported here may also be explained by a lack of relative importance attributed by NIPs and PIPs to the cost of medicines prescribed. Alternatively, it may be explained by the fact that many of the consultations were focused on medicines prescribed for long term conditions: thus an initial medicine may have previously been prescribed, in many instances by another health care professional. In such cases the prescriber may have been reluctant to change an already prescribed drug to a less expensive one, an explanation that supports other results in the larger study. 11 For PIPs the majority of consultations were review consultations. For NIPs the consultations were for a mix of acute and long term conditions. Evidence of skill in history-taking, assessment and diagnosis was present in most consultations. Nevertheless, raters' comments suggest the comprehensiveness of this key pre-requisite to prescribing could be improved. This finding echoes that rom a previous evaluation of nurses' consultations. 12 We suggest health care organisations need to assure themselves that nurses embarking on prescribing training are in possession of the pre-requisite history-taking, clinical assessment and diagnosis skills, 1 whilst those involved in prescribing training for pharmacists must ensure that knowledge and skills in these areas are delivered within the prescribing training programme.
Study limitations
Limitations of the study are the self-selected sample of nurse and pharmacist prescribers, and participants' awareness of audio-recording, which may have resulted in atypical consultations. In one of our sites, only one consultation was recorded, so the data are predominantly from eight not nine sites. However, approximately half of survey participants opted to be considered for the case site data collection, indicating those who expressed interest were not atypical. Sites were selected for their representativeness of nonmedical prescribing settings. Additionally, participants lacked awareness of the MAI criteria used to analyze consultations. Data from our national survey indicate that the medicines included in the analysis were representative of those currently prescribed by nurse and pharmacist prescribers. 11 Our study design differs from previous studies using the MAI in the large number of raters and the adapted MAI rating system. Twenty multi-professional raters made ratings in total, and four assessed each consultation. Whilst this could be regarded as a strength of the study, it adds to the potential for variation in our calculation of reliability. The levels of positive agreement are comparable to other studies using two raters. 19, 20 Overall, the percentage agreement on indicators and for weighted total scores suggest a satisfactory level of agreement between raters.
Conclusions
Current reform of prescribing services to allow the prescription of medicines to patients by nurses and pharmacists offers a safe and potentially clinically effective service. Consideration may now need to be given to whether NMP needs to more adequately address prescribing across multiple conditionsto reflect population health care need. Whilst there is potential for improvement in the relative costs of medicines prescribed, and in assessment and diagnostic skills, the direction and form of NMP policy in England is satisfactory and may offer health care commissioners an alternative to medical prescribing for some groups of patients.
